The dailysciencedigest’s Podcast

Child Abuse in COVID-19 — Why ICU Admissions Rose as Cases Fell

Child abuse during COVID-19 pandemic: why ICU admissions rose as overall child maltreatment hospital admissions fell
Unique CMAJ-based analysis of COVID-19 lockdown impact on child abuse, PICU admissions, and hidden maltreatment in infants
Understand how pandemic effects on children changed abuse patterns and what it means for child protection during lockdowns and stay-at-home orders
What You'll Learn:
How a 31% decrease in Canadian hospital admissions for child maltreatment among children under 2 during the March–June 2020 lockdown can mask ongoing abuse
Why admissions for child maltreatment rebounded to baseline from July–October 2020 while ICU admissions for maltreatment rose above baseline (rate ratio ≈1.3)
What the 27% drop in Québec child-protection reports in spring 2020 reveals about hidden child abuse during the pandemic
How COVID-19 stay-at-home orders changed who noticed and reported infant abuse and neglect—and who didn’t
Ways clinicians and hospitals can interpret declining maltreatment admissions without assuming real decreases in abuse
How to use hospital data, child-protection reports, and community signals together to detect pandemic-era child abuse patterns
Implications of these findings for designing child protection strategies in future lockdowns and public health emergencies

Ancient Fingerprint Discovery — Iron Age Hjortspring War Boat

Ancient fingerprint discovery on the Hjortspring boat reveals new secrets of an Iron Age war boat and ancient Scandinavian ship technology.
This episode dives into Baltic Sea archaeology, a 2,400 year old boat, and how a single print connects us to Iron Age warriors and ancient shipbuilding.
Learn how scientists decoded caulking, cords, and materials to trace the Hjortspring war boat’s origins and voyages across Iron Age Scandinavia.
What You'll Learn:
How an ancient fingerprint discovery on the Hjortspring boat was made and why it matters for Iron Age war boat research
Key facts about the Hjortspring boat: its 2,400-year age, dimensions, crew capacity, and role as an ancient Scandinavian ship of war
What lime-wood planks, lime-bast sewing cords, and organic caulking reveal about ancient shipbuilding techniques in Iron Age Scandinavia
How traces of pine pitch and animal fat in the caulking help archaeologists pinpoint possible source regions along the Baltic Sea
Why the materials likely came from pine-rich regions east of Denmark and what this suggests about long-distance seafaring and trade networks
What the Hjortspring boat can tell us about Iron Age warriors, warfare, and a carefully planned seaborne attack on the island of Als
How modern scientific analysis of tiny residues (like pitch and fat) can transform our understanding of Danish archaeology and ancient maritime history

Health Data and AI — When UK Public Trusts Data Sharing

Health data and AI: UK public opinion on health data sharing and public trust in AI
New NDORMS focus groups reveal conditional support for NHS data and artificial intelligence when benefits, safeguards, and ethics are clear
Learn how public trust, patient data privacy, and ethical AI in medicine shape the future of sharing medical data for research in the UK
What You'll Learn:
• Why UK public opinion on health data sharing for AI is strongly tied to visible NHS-led public benefit and not just abstract promises
• How clear explanations of risks, safeguards, and outcomes can dramatically increase support for sharing medical data for research and AI development
• Under what conditions participants were more willing to back NHS-led, non-commercial AI projects versus for-profit tech firm involvement
• What focus groups said about NHS control, profit-sharing, and faster care as prerequisites for using patient data in commercial AI tools
• How resources like UK Biobank have enabled thousands of studies while reporting zero re-identification incidents—and why that matters for public trust
• Practical principles for designing ethical AI in healthcare that align with patient expectations on privacy, consent, and transparency
• How findings from a BMJ Digital Health and AI study can guide policymakers, hospital leaders, and researchers in communicating about data use
About the Guest:
This episode features researchers involved in a new NDORMS study published in BMJ Digital Health & AI, who work at the intersection of health data science, medical ethics, and public engagement. Drawing on in-depth UK focus groups, they translate public concerns and expectations into practical guidance for health systems, regulators, and AI developers. Their work centers public voices in debates about NHS data and artificial intelligence to inform safer, more trusted innovation.
Episode Content:
00:00 - Introduction: Why health data and AI need public trust
04:15 - Background: NHS data, AI in healthcare ethics, and recent policy debates
10:30 - Inside the NDORMS study: How the UK focus groups were designed and who took part
17:45 - Conditional support: When people back NHS-led, non-commercial AI projects
24:20 - The commercial question: Public views on for-profit tech firms using NHS data
31:40 - Consent, control, and safeguards: What “trustworthy” data sharing looks like
39:10 - UK Biobank as a case study: Scale, impact, and zero reported re-identification incidents
46:25 - Turning insights into action: Practical guidance for policymakers, clinicians, and AI developers
54:00 - Future directions: Public engagement, regulation, and the next wave of ethical AI in medicine
Health data and AI are reshaping the NHS—but only if the public is on board. This episode dives into new research on UK public opinion on health data sharing, drawing on in-depth NDORMS focus groups that explore what makes people willing—or unwilling—to share their medical records for AI research.
You’ll hear how participants responded when potential benefits were made concrete, such as better diagnostics, faster care, and more efficient NHS services. The conversation unpacks why many people express strong support for non-commercial, NHS-led AI projects aimed at clear public good, while showing far more skepticism toward sharing data with for-profit tech companies.
We break down the conditions that increased support: robust privacy safeguards, meaningful consent, transparent governance, ongoing public oversight, and guarantees that the NHS retains control over how data and resulting AI tools are used. The discussion also examines how expectations shift when financial profit is involved, and why some participants want patients or the NHS to share in that value if their data underpins commercial tools.
The episode highlights the UK Biobank as a large-scale proof of concept for secure health data use—enabling thousands of research papers with zero reported re-identification incidents—and what that example does and does not resolve in public debates about trust. Throughout, we connect these findings to broader questions in AI in healthcare ethics, patient data privacy, and the responsibilities of health systems and regulators.
Whether you’re working in digital health, designing AI tools for medicine, setting NHS data policy, or simply a patient curious about how your records might be used, this episode offers a clear, research-based guide to what the UK public actually says it needs in order to trust sharing medical data for research and AI.
What You'll Learn:
Why UK public opinion on health data sharing for AI is tightly linked to visible NHS-led public benefit and clear explanations of outcomes
How thoughtful communication about risks, safeguards, and governance can significantly increase willingness to share medical data for research
What focus group participants considered acceptable conditions for NHS-led, non-commercial AI projects versus commercial, for-profit initiatives
How expectations around NHS control, benefit-sharing, and faster access to care shape public trust in AI and data partnerships
What the UK Biobank experience shows about large-scale health data use, research impact, and maintaining public confidence through zero reported re-identification incidents
Which ethical principles—transparency, accountability, consent, and oversight—people want embedded in AI in healthcare systems
How policymakers, clinicians, and AI developers can use evidence from the BMJ Digital Health and AI study to design more trusted data-sharing frameworks
About the Guest:
This episode features researchers involved in a new NDORMS study published in BMJ Digital Health & AI, who work at the intersection of health data science, medical ethics, and public engagement. Drawing on in-depth UK focus groups, they translate public concerns and expectations into practical guidance for health systems, regulators, and AI developers. Their work centers public voices in debates about NHS data and artificial intelligence to inform safer, more trusted innovation.

New Exoplanet Discovery — Rocky Outer Orbit Defies Theory

New exoplanet discovery: rocky planet outer orbit defies planet formation theory around red dwarf LHS 1903
Space science podcast episode on a LHS 1903 exoplanet that challenges how planets form in red dwarf planetary systems
Understand why this rocky vs gas planets surprise matters for planet formation theory and future exoplanet searches
What You'll Learn:
How the new exoplanet discovery around LHS 1903 breaks the classic pattern of rocky inner planets and gas giants farther out
Why finding a rocky planet in an outer orbit challenges standard planet formation theory models
Key details of the LHS 1903 red dwarf planetary system, including its inner planets b, c, and d and their compact orbits
The unique properties of planet LHS 1903 e: its Earth-like mass and radius, colder temperature, and 0.6 AU orbit
What the 37-day rotation period and M3V classification of LHS 1903 tell astronomers about its environment and planetary system
How scientists measure exoplanet size, mass, and equilibrium temperature to distinguish rocky planets from gas planets
What this red dwarf planet system means for our understanding of how planets form and migrate over time
How this exoplanet podcast episode connects LHS 1903 e to broader questions about rocky vs gas planets and future discoveries

Origins of Life from Asteroid Bennu — OSIRIS-REx Amino Acid Clues

Asteroid Bennu and the origins of life: new amino acid clues from OSIRIS-REx samples
How Bennu asteroid dust, frozen ice radiation chemistry, and space chemistry rewrite theories of how life began on Earth
Discover fresh evidence for multiple prebiotic chemistry pathways and what Bennu’s amino acids reveal about life’s building blocks in space
What You'll Learn:
Why the OSIRIS-REx sample from asteroid Bennu is a game‑changer for studying the origins of life and amino acids in space
What it means that Bennu’s dust contains ~4.7 wt % carbon and ~6 wt % water‑bearing minerals for prebiotic chemistry potential
How amino acids with D/H ratios up to 5× Earth’s oceans point to formation in frozen ice exposed to radiation instead of warm liquid water
What magnesium–sodium phosphate grains reveal about Bennu’s minimal thermal alteration (below ~50 °C) and preservation of delicate space chemistry signatures
How Bennu’s isotopic fingerprints differ from well‑studied meteorites, and why that suggests multiple pathways for creating life’s ingredients in the early Solar System
The role of frozen ice radiation chemistry in synthesizing complex organic molecules and how this challenges traditional ‘warm pond’ origin‑of‑life scenarios
What Bennu’s composition tells us about how water, organics, and prebiotic molecules may have been delivered to early Earth
How future OSIRIS-REx analyses of Bennu asteroid dust could refine our understanding of how life’s chemistry starts on other worlds

Teen Screen Addiction & Mental Health — New Research Explained

Teen screen addiction and mental health: what new science reveals about digital addiction in adolescents
Fresh data on social media and teen mental health, problematic screen use, and youth smartphone addiction explained in plain language
Understand real risks behind screen time and mental health so you can better protect teens’ sleep, mood, and long‑term wellbeing
What You'll Learn:
How a major new study tracked 11–12-year-olds to measure teen screen addiction, social media use, and video game habits over time
The exact prevalence of problematic screen use: 16% for phones, 9.1% for social media, and 3.7% for video games in early adolescence
Why digital addiction in adolescents was more strongly linked to depression, anxiety, and suicidal thoughts than overall daily screen time
What an adjusted odds ratio of 1.82 for suicidal ideation really means for problematic phone users compared with non-problematic users
How keeping phones in the bedroom is tied to 21 minutes less sleep on average and why teen sleep and screen time are so tightly connected
Practical ways parents and caregivers can respond to problematic screen use without panic, shame, or constant conflict
How to talk with teens about social media and mental health in a way that validates their online lives while setting healthier boundaries
Simple, research-informed strategies families can use to reduce screen time and depression risk while still letting kids stay connected

Preeclampsia Prevention — Daily Low‑Dose Aspirin in Pregnancy

Aspirin in pregnancy for preeclampsia prevention — what every clinician and expecting parent should know. New data on routine daily low-dose aspirin, maternal fetal medicine guidelines, and preventing severe pregnancy complications. Understand how aspirin therapy for preeclampsia can reduce life‑threatening outcomes for high‑risk pregnancies worldwide.
What You'll Learn:
Global impact and incidence of preeclampsia, including maternal and perinatal mortality statistics from WHO.
How daily low-dose aspirin works in pregnancy to lower the risk of preeclampsia and severe preeclampsia.
Which patients should be considered "at risk" for preeclampsia and how to screen them at the first prenatal visit.
How to apply evidence from the Roberge 2023 meta-analysis to real-world high risk pregnancy care decisions.
The optimal aspirin regimen in pregnancy (dose, timing, and duration) used in the U.S. and Europe for preeclampsia prevention.
How starting aspirin before 16 weeks’ gestation changes outcomes, including a 53% reduction in severe preeclampsia.
Practical counseling tips for discussing aspirin therapy with pregnant patients, including benefits, safety, and adherence.
How new research from the 2026 SMFM Pregnancy Meeting may influence future prenatal visit guidelines and maternal fetal medicine practice.

Best ADHD Treatments — New 2026 Research on What Really Works

Best ADHD treatments in 2026: ADHD treatment evidence and what really works for ADHD
A massive new ADHD research 2026 mega-review of 212 meta-analyses (3.8M+ data points) reveals ADHD study results across medication, therapy, and combined care
Learn how to navigate ADHD treatment options using real evidence, not hype—so you can make clearer, more confident decisions with your clinician
What You'll Learn:
How a global synthesis of 212 meta-analyses and 3.8 million+ participant data points reshapes our understanding of ADHD treatment evidence
What the numbers actually say about stimulant medications, including a pooled SMD of −0.78 for core symptoms in children (and what a “large effect” means in real life)
Why only 9% of ADHD treatment studies followed people longer than 12 months—and what that means for anyone on long‑term treatment
How medication compares with therapy and skills-based interventions, and where combined approaches may offer advantages
How to use the new interactive public website to explore ADHD study results by age, treatment type, and outcome domain
Key questions to ask your doctor or therapist when discussing evidence-based ADHD treatment options
Common myths about what works for ADHD, and how high-quality science can confirm or challenge them
How to think critically about short‑term vs long‑term benefits, side effects, and real‑world functioning when choosing treatments

Child Fracture Pain Relief — Ultrasound-Guided Nerve Blocks

Pediatric femur fracture pain control using ultrasound-guided nerve blocks
Opioid-sparing nerve block for broken leg in children in real-world pediatric emergency medicine settings
Learn how ultrasound-guided nerve blocks can cut opioid use by 74% while giving kids faster, better pain relief after femur fractures
What You'll Learn:
Why femur fractures are among the top three most painful injuries in childhood and what that means for emergency pain control strategies
How ultrasound-guided femoral nerve blocks work for broken leg pain in children and when to consider them over opioids alone
Key findings from the multicenter study showing a 74% reduction in total morphine milligram equivalents over the first 24 hours with nerve blocks
How pain scores compared: median pain 60 minutes after intervention with nerve block vs opioids alone, and what that means at the bedside
Practical considerations for implementing ultrasound-guided nerve blocks in pediatric emergency care, including workflow and team coordination
How nerve blocks fit into non-opioid pain management for kids and broader opioid-sparing pain relief strategies in the ED
Counseling points for families about leg fracture treatment options, risks, and benefits of nerve blocks versus traditional opioid-based regimens
About the Guest:
Zachary Binder, MD, is an associate professor of pediatrics and a pediatric emergency medicine physician specializing in acute pain management for children. He led the first large, prospective, multicenter study evaluating ultrasound-guided nerve blocks for pediatric femur fractures in emergency settings. His work focuses on evidence-based, opioid-sparing strategies to improve comfort and outcomes for injured children.

Gut and Liver Health — New Indole Microbiome Discovery

Gut health and liver health: new indole gut compound discovery for fatty liver disease prevention
Unique microbiome and metabolic health insights linking pregnancy diet and baby health, gut bacteria and liver protection, and non alcoholic fatty liver disease
Understand how diet and microbiome science can protect the liver, lower fatty liver risk, and support healthier babies
What You'll Learn:
How gut health and liver health are biologically connected through the gut–liver axis and portal blood circulation
Why an indole gut compound made by certain gut bacteria may help protect against non alcoholic fatty liver disease across generations
What current evidence suggests about indole levels in healthy people versus NAFLD patients—and why this needs careful verification before clinical use
How a Colorado mouse study showed that offspring of indole-supplemented dams had 58% lower hepatic triglycerides and 32% better glucose tolerance on a high fat, high sugar diet
Practical implications of how diet affects baby liver development during pregnancy, and what this might mean for long‑term metabolic health
Why more than 100 bacterial species carrying the tnaA gene can produce indole, and what that reveals about the microbiome’s role in liver protection
Realistic ways future nutrition, supplements, or microbiome-targeted therapies could help in fatty liver disease prevention
Key limitations of animal research, what still needs to be proven in humans, and how to interpret microbiome science podcast claims responsibly